<DOC>
<DOCNO>
EP-0004271
</DOCNO>
<TEXT>
<DATE>
19791003
</DATE>
<IPC-CLASSIFICATIONS>
G01N-33/66 C12Q-1/56 G01N-33/86 
</IPC-CLASSIFICATIONS>
<TITLE>
process and reagent for the determination of biologically active heparins in plasma
</TITLE>
<APPLICANT>
boehringer mannheim gmbhde<sep>boehringer mannheim gmbh <sep>boehringer mannheim gmbh68298 mannheimde   <sep>
</APPLICANT>
<INVENTOR>
bartl knut drde<sep>lill helmut drde<sep>ziegenhorn joachim drde<sep>bartl, knut, dr.<sep>lill, helmut, dr.<sep>ziegenhorn, joachim, dr.<sep>bartl, knut, dr.an der leiten 11d-8132 tutzingde<sep>lill, helmut, dr.zugspitzstrasse 24d-8121 wielenbachde<sep>ziegenhorn, joachim, dr.ina-seidel-weg 1d-8130 starnbergde<sep>
</INVENTOR>
<ABSTRACT>
The biologically active heparin in the plasma is determined by proteolysis by thrombin or factor Xa in the presence of a chromogenic substrate, such as a peptide, which has a p-nitroanilide group in amide bond and measuring the dye formed, working in the absence of added antithrombin III.
</ABSTRACT>
</TEXT>
</DOC>
